Risk Factors and Genetics of Atrial Fibrillation

Cardiology Clinics

Volumn 32, Issue 4, 2014, Pages 485-494

  Anumonwo, Justus M B ^a   Kalifa, Jérôme ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Division of Cardiovascular Medicine   (United States)

Author keywords

AF; AF genetics; Atrial Fibrillation; Genetic variants and AF; Risk factors

Indexed keywords

ION CHANNEL; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR PITX2;

AGING; ALCOHOL CONSUMPTION; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EXERCISE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; INHERITANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDERED BREATHING; SMOKING; THYROID DISEASE; AGE; ATRIAL FIBRILLATION; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR;

AGE FACTORS; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE; HUMANS; HYPERTENSION; PREVALENCE; RISK FACTORS;

EID: 84927550503     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2014.07.007     Document Type: Review

References (102)

1. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation the framingham heart study. Circulation 2004, 110:1042-1046.
2. Heeringa J., van der Kuip D.A., Hofman A., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the rotterdam study. Eur Heart J 2006, 27:949-953.
3. Andrade J., Khairy P., Dobrev D., et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 2014, 114:1453-1468.
4. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119.
5. Kim M.H., Johnston S.S., Chu B.C., et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the united states. Circ Cardiovasc Qual Outcomes 2011, 4:313-320.
6. Oldgren J., Healey J.S., Ezekowitz M., et al. Variations in etiology and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the re-ly afregistry. Circulation 2014, 10.1161/CIRCULATIONAHA.113.005451.
7. Wyse D.G., Van Gelder I.C., Ellinor P.T., et al. Lone atrial fibrillation: does it exist? A "white paper" of the journal of the American College of Cardiology. JAm Coll Cardiol 2014, 63(17):1715-1723.
8. Benjamin E.J., Levy D., Vaziri S.M., et al. Independent risk factors for atrial fibrillation in a population-based cohort. JAMA 1994, 271:840.
9. Feinberg W.M., Blackshear J.L., Laupacis A., et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995, 155:469-473.
10. Tadros R., Ton A.T., Fiset C., et al. Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics and mechanisms. Can J Cardiol 2014, 30(7):783-792.
11. Koura T., Hara M., Takeuchi S., et al. Anisotropic conduction properties in canine atria analyzed by high-resolution optical mapping preferential direction of conduction block changes from longitudinal to transverse with increasing age. Circulation 2002, 105:2092-2098.
12. Anyukhovsky E.P., Sosunov E.A., Plotnikov A., et al. Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovasc Res 2002, 54:462-469.
13. Schotten U., Verheule S., Kirchhof P., et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011, 91:265-325.
14. Kannel W.B., Abbott R.D., Savage D.D., et al. Epidemiologic features of chronic atrial fibrillation: the framingham study. NEngl J Med 1982, 306:1018-1022.
15. Kannel W.B., Wolf P.A., Benjamin E.J., et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998, 82:2N-9N.
16. Choisy S.C., Arberry L.A., Hancox J.C., et al. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts. Hypertension 2007, 49:498-505.
17. Kistler P.M., Sanders P., Dodic M., et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 2006, 27:3045-3056.
18. Roy D., Talajic M., Dubuc M., et al. Atrial fibrillation and congestive heart failure. Curr Opin Cardiol 2009, 24:29.
19. Kannel W.B., Abbott R.D., Savage D.D., et al. Coronary heart disease and atrial fibrillation: the framingham study. Am Heart J 1983, 106:389-396.
20. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the framingham heart study. Circulation 1998, 98:946-952.
21. Kannel W.B., Benjamin E.J. Status of the epidemiology of atrial fibrillation. Med Clin North Am 2008, 92:17-40.
22. Krahn A.D., Manfreda J., Tate R.B., et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the manitoba follow-up study. Am J Med 1995, 98:476-484.
23. Maisel W.H., Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003, 91:2-8.
24. Jais P., Peng J.T., Shah D.C., et al. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. JCardiovasc Electrophysiol 2000, 11:623-625.
25. Tsang T.S., Gersh B.J., Appleton C.P., et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. JAm Coll Cardiol 2002, 40:1636-1644.
26. Cha T.J., Ehrlich J.R., Zhang L., et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 2004, 109:412-418.
27. Shinagawa K., Shi Y.F., Tardif J.C., et al. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 2002, 105:2672-2678.
28. Tanaka K., Zlochiver S., Vikstrom K.L., et al. Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure. Circ Res 2007, 101:839-847.
29. Trayanova N.A. Mathematical approaches to understanding and imaging atrial fibrillation: significance for mechanisms and management. Circ Res 2014, 114:1516-1531.
30. Savelieva I., Kakouros N., Kourliouros A., et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for european society of cardiology guidelines. Part I: primary prevention. Europace 2011, 13:308-328.
31. James T.N. Myocardial infarction and atrial arrhythmias. Circulation 1961, 24:761-776.
32. Crenshaw M., Brian S., Ward M., et al. Atrial fibrillation in the setting of acute myocardial infarction: the Gusto-I experience. JAm Coll Cardiol 1997, 30:406-413.
33. Wong C.K., White H.D., Wilcox R.G., et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the Gusto-III experience. Am Heart J 2000, 140:878-885.
34. Goldberg R.J., Yarzebski J., Lessard D., et al. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. Am Heart J 2002, 143:519-527.
35. Tsang T., Barnes M.E., Bailey K.R., et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001, 76:467.
36. Moller J.E., Hillis G.S., Oh J.K., et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 2003, 107:2207.
37. Cushing E., Feil H., Stanton E., et al. Infarction of the cardiac auricles (atria): clinical, pathological, and experimental studies. Br Heart J 1942, 4:17.
38. Wartman W., Souders J. Localization of myocardial infarcts with respect to the muscle bundles of the heart. Arch Pathol 1950, 50:329.
39. Mayuga R., Singer D. Atrial infarction: clinical significance and diagnostic criteria. Practical Cardiol 1985, 11:142-160.
40. Bunc M., Starc R., Podbregar M., et al. Conversion of atrial fibrillation into a sinus rhythm by coronary angioplasty in a patient with acute myocardial infarction. Eur J Emerg Med 2001, 8:141.
41. Pehkonen E., Honkonen E., Makynen P., et al. Stenosis of the right coronary artery and retrograde cardioplegia predispose patients to atrial fibrillation after coronary artery bypass grafting. Thorac Cardiovasc Surg 1998, 46:115-120.
42. Nishida K., Qi X.Y., Wakili R., et al. Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model. Circulation 2011, 10.1161/CIRCULATIONAHA.110.972778.
43. Jayachandran J.V., Zipes D.P., Weksler J., et al. Role of the na+/h+ exchanger in short-term atrial electrophysiological remodeling. Circulation 2000, 101:1861-1866.
44. Sinno H., Derakhchan K., Libersan D., et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation 2003, 107:1930-1936.
45. Yamazaki M., Avula U.M., Bandaru K., et al. Acute regional left atrial ischemia causes acceleration of atrial drivers during atrial fibrillation. Heart Rhythm 2013, 10(6):901-909.
46. Al Chekakie M.O., Welles C.C., Metoyer R., et al. Pericardial fat is independently associated with human atrial fibrillation. JAm Coll Cardiol 2010, 56:784-788.
47. Batal O., Schoenhagen P., Shao M., et al. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol 2010, 3:230-236.
48. Abed H.S., Wong C.X., Brooks A.G., et al. Periatrial fat volume is predictive of atrial fibrillation severity. Heart Rhythm 2010, 7:S327.
49. Tsao H.M., Hu W.C., Wu M.H., et al. Abundance and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation. Heart Rhythm 2010, 7:S327.
50. Shin S.Y., Yong H.S., Lim H.E., et al. Total and interatrial epicardial adipose tissues are independently associated with left atrial remodeling in patients with atrial fibrillation. JCardiovasc Electrophysiol 2011, 22:647-655.
51. Thanassoulis G., Massaro J.M., O'Donnell C.J., et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2010, 3:345-350.
52. Iacobellis G., Corradi D., Sharma A.M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005, 2:536-543.
53. Gong D., Yang R., Munir K.M., et al. New progress in adipocytokine research. Curr Opin Endocrinol Diabetes Obes 2003, 10:115-121.
54. Karmazyn M., Purdham D.M., Rajapurohitam V., et al. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc Res 2008, 79:279-286.
55. Veiga-Lopez A., Moeller J., Patel D., et al. Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep. Endocrinology 2013, 154:1731-1742.
56. Kim J.Y., Park J.Y., Kim O.Y., et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and q-tof mass spectrometry (uplc-q-tof ms). JProteome Res 2010, 9:4368-4375.
57. Iacobellis G., Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. JClin Endocrinol Metab 2005, 90:6300-6302.
58. Silaghi A., Piercecchi-Marti M.D., Grino M., et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity (Silver Spring) 2008, 16:2424-2430.
59. Sacks H.S., Fain J.N. Human epicardial adipose tissue: a review. Am Heart J 2007, 153:907-917.
60. Pantanowitz L. Fat infiltration in the heart. Heart 2001, 85:253.
61. Kankaanpaa M., Lehto H.R., Parkka J.P., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. JClin Endocrinol Metab 2006, 91:4689-4695.
62. Graner M., Siren R., Nyman K., et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. JClin Endocrinol Metab 2013, 98:1189-1197.
63. Gami A.S., Pressman G., Caples S.M., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110:364-367.
64. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. JAm Coll Cardiol 2007, 49:565-571.
65. Fein A.S., Shvilkin A., Shah D., et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. JAm Coll Cardiol 2013, 62:300-305.
66. Ng C.Y., Liu T., Shehata M., et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011, 108:47-51.
67. Vaziri S.M., Larson M.G., Benjamin E.J., et al. Echocardiographic predictors of nonrheumatic atrial fibrillation. The framingham heart study. Circulation 1994, 89:724-730.
68. Franz M.R., Bode F. Acute stretch effects on atrial electrophysiology. Cardiac mechano-electric coupling and arrhythmias 2011, 168. Oxford University Press, Oxford, UK. P. Khol, F. Sachs, M. Franz (Eds.).
69. Franz M.R., Bode F. Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case. Prog Biophys Mol Biol 2003, 82:163-174.
70. Kalifa J., Jalife J., Zaitsev A.V., et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 2003, 108:668-671.
71. Yamazaki M., Mironov S., Taravant C., et al. Heterogeneous atrial wall thickness and stretch promote scroll waves anchoring during atrial fibrillation. Cardiovasc Res 2012, 94(1):48-57.
72. Keren G., Etzion T., Sherez J., et al. Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Am Heart J 1987, 114:1146-1155.
73. Haïat R., Scemama A., Halphen C., et al. Spontaneous reduction of late chronic atrial fibrillation after mitral valvuloplasty. Echocardiographic evidence of the restoration of mechanical atrial activity. Arch Mal Coeur Vaiss 1997, 90:835-839. [in French].
74. Alpert J.S., Petersen P., Godtfredsen J. Atrial fibrillation: natural history, complications, and management. Annu Rev Med 1988, 39:41-52.
75. Coumel P. Atrial fibrillation: one more sporting inconvenience?. Eur Heart J 2002, 23:431-433.
76. Mozaffarian D., Furberg C.D., Psaty B.M., et al. Physical activity and incidence of atrial fibrillation in older adults the cardiovascular health study. Circulation 2008, 118:800-807.
77. Olshansky B., Sullivan R. Increased prevalence of atrial fibrillation in the endurance athlete: potential mechanisms and sport specificity. Phys Sportsmed 2014, 42:45-51.
78. Turagam M.K., Velagapudi P., Kocheril A.G. Atrial fibrillation in athletes. Am J Cardiol 2012, 109:296-302.
79. Guasch E., Benito B., Qi X., et al. Atrial fibrillation promotion by endurance exercisedemonstration and mechanistic exploration in an animal model. JAm Coll Cardiol 2013, 62:68-77.
80. Wolff L. Familial auricular fibrillation. NEngl J Med 1947.
81. Arnar D.O., Thorvaldsson S., Manolio T.A., et al. Familial aggregation of atrial fibrillation in iceland. Eur Heart J 2006, 27:708-712.
82. Darbar D., Herron K.J., Ballew J.D., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. JAm Coll Cardiol 2003, 41:2185-2192.
83. Ellinor P.T., Yoerger D.M., Ruskin J.N., et al. Familial aggregation in lone atrial fibrillation. Hum Genet 2005, 118:179-184.
84. Fox C.S., Parise H., D'Agostino R.B., et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004, 291:2851-2855.
85. Oyen N., Ranthe M.F., Carstensen L., et al. Familial aggregation of lone atrial fibrillation in young persons. JAm Coll Cardiol 2012, 60:917-921.
86. Lubitz S.A., Ozcan C., Magnani J.W., et al. Genetics of atrial fibrillation: implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol 2010, 3:291-299.
87. Olesen M.S., Andreasen L., Jabbari J., et al. Very early-onset lone atrial fibrillation patients have a high prevalence of rare variants in genes previously associated with atrial fibrillation. Heart Rhythm 2014, 11:246-251.
88. Olesen M.S., Nielsen M.W., Haunso S., et al. Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet 2014, 22:297-306.
89. Weeke P., Parvez B., Blair M., et al. Candidate gene approach to identifying rare genetic variants associated with lone atrial fibrillation. Heart Rhythm 2014, 11:46-52.
90. Yang Y., Li J., Lin X., et al. Novel kcna5 loss-of-function mutations responsible for atrial fibrillation. JHum Genet 2009, 54:277-283.
91. Olesen M.S., Yuan L., Liang B., et al. High prevalence of long qt syndrome-associated scn5a variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet 2012, 5:450-459.
92. Arnestad M., Crotti L., Rognum T.O., et al. Prevalence of long-qt syndrome gene variants in sudden infant death syndrome. Circulation 2007, 115:361-367.
93. Hodgson-Zingman D.M., Karst M.L., Zingman L.V., et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. NEngl J Med 2008, 359:158-165.
94. Abraham R.L., Yang T., Blair M., et al. Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. JMol Cell Cardiol 2010, 48:181-190.
95. Zhang X., Chen S., Yoo S., et al. Mutation in nuclear pore component nup155 leads to atrial fibrillation and early sudden cardiac death. Cell 2008, 135:1017-1027.
96. Gudbjartsson D.F., Arnar D.O., Helgadottir A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007, 448:353-357.
97. Gage P.J., Suh H., Camper S.A. Dosage requirement of pitx2 for development of multiple organs. Development 1999, 126:4643-4651.
98. Mommersteeg M.T., Brown N.A., Prall O.W., et al. Pitx2c and nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 2007, 101:902-909.
99. Johnson J.N., Tester D.J., Perry J., et al. Prevalence of early-onset atrial fibrillation in congenital long qt syndrome. Heart Rhythm 2008, 5:704-709.
100. Ritchie M.D., Rowan S., Kucera G., et al. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. JAm Coll Cardiol 2012, 60:1173-1181.
101. Ackerman M.J., Priori S.G., Willems S., et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011, 8:1308-1339.
102. Everett B.M., Cook N.R., Conen D., et al. Novel genetic markers improve measures of atrial fibrillation risk prediction. Eur Heart J 2013, 34:2243-2251.